No Picture
News

Therapeutic Solutions International Launches Campbell Neurosciences Inc as First Suicide Focused Regenerative Psychiatry Biotechnology Company

Campbell Neurosciences to License Key Intellectual Property Assets as Clinical Trials of Campbell Score and Kaihani Score are Ongoing

OCEANSIDE, Calif., Dec. 31, 2020 /PRNewswire/ — Therapeutic Solutions International, Inc., (OTC Markets: TSOI), ann… […]

No Picture
News

Halozyme Announces Roche Receives European Commission Approval For Phesgo® (Fixed-Dose Combination Of Perjeta® And Herceptin® For Subcutaneous Injection) Utilizing Halozyme’s ENHANZE® Technology For The Treatment Of Patients With HER2-Positive Breast Cancer

– Phesgo® Can be Administered in 5 to 8 Minutes Compared with Hours for the Standard Sequential IV Administration of Perjeta® and Herceptin® — First Subcutaneous Fixed-dose Combination of Two Monoclonal Antibodies Approved in Europe Utilizing Halozyme… […]

No Picture
News

Menon Advances as Finalist in $6 Million XPRIZE Rapid COVID Testing Competition with Molecular Mirror(TM) Platform Technology

Breakthrough Molecular Mirror(TM) Detection Technology Allows for Screening of More Than 100,000 Patient Specimens Per Day Using Standard MRI Systems Available in Hospitals

SAN DIEGO, Dec. 22, 2020 /PRNewswire/ — Menon Biosensors, Inc. (“Menon” or t… […]

No Picture
News

Evofem Biosciences to Participate in Medicaid National Drug Rebate Program for Phexxi® Effective January 1, 2021

Approximately 25 Million Adult Women Covered by Medicaid

SAN DIEGO, Dec. 22, 2020 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it has entered into an agreement with the U.S. Centers for Medicare and Medicaid Services (CMS)… […]

No Picture
News

Therapeutic Solutions International Files Patent on NeuroLeukin(TM) Personalized Immunotherapy for Opioid Addiction

Campbell Neurosciences Division Expands its “Regenerative Psychiatry” Approach to Address the $179 Billion Dollar Prescription Opioid Epidemic

OCEANSIDE, Calif., Dec. 21, 2020 /PRNewswire/ — Therapeutic Solutions International, Inc., (OTC Markets: T… […]